Related Experiment Video

Updated: Sep 18, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K

NRG-BR008/HERO study: a Phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast

Lior Z Braunstein1, Melissa P Mitchell2, Hanna Bandos3

  • 1Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Future Oncology (London, England)
|June 27, 2025
PubMed
Abstract

Keywords:
Breast-conservation therapyHER2-positive breast cancerHER2-targeted therapyadjuvant breast radiotherapybreast cancer treatmentoncological outcomesquality of life outcomes

More Related Videos

Stereotactic Radiosurgery for Gynecologic Cancer10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.3K
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

46.9K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K